Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 1/20 | 0.41 |
| ▸ | OGA | O60502 | 3/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.33 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.32 |
| ▸ | ASGR1 | P07306 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TREH | O43280 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13389865 | 0.83 | OGA (0.46) | OGATREH | |
| SCHEMBL10803673 | 0.83 | OGA (0.46) | OGATREH | |
| SCHEMBL18857573 | 0.83 | OGA (0.46) | OGATREH | |
| SCHEMBL23603516 | 0.83 | OGA (0.46) | OGATREH | |
| SCHEMBL24916748 | 0.83 | OGA (0.39) | OGAASGR1CYP2C9CYP2C19TREH | |
| SCHEMBL10557474 | 0.83 | OGA (0.46) | OGATREH | |
| SCHEMBL23705039 | 0.83 | OGA (0.46) | OGATREH | |
| SCHEMBL23794126 | 0.83 | OGA (0.39) | OGAASGR1CYP2C9CYP2C19TREH | |
| SCHEMBL16221822 | 0.83 | OGA (0.46) | OGATREH | |
| SCHEMBL12085189 | 0.83 | OGA (0.46) | OGATREH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11161868-B2 | N-acetylated sialic acids and related sialosides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11161868-B2 | N-acetylated sialic acids and related sialosides | FUT5, B3GNT2, NEU3 | FUCA1 67/4885OGA 68/4885GLA 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.